NKMAX CO., Ltd. (182400.KQ)
- Previous Close
2,020.00 - Open
0.00 - Bid --
- Ask --
- Day's Range
2,020.00 - 2,020.00 - 52 Week Range
1,550.00 - 8,205.00 - Volume
0 - Avg. Volume
7,189,268 - Market Cap (intraday)
50.227B - Beta (5Y Monthly) 1.10
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date May 13, 2024 - May 17, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
NKMAX CO., Ltd. manufactures and sells biological products in South Korea. The company offers anti-cancer immunotherapy treatment that activates the immune cells in body to kill the cancer cells; natural killer cell activity test for cancer patients; NK VUE Kit, an NK cell activity test that quantitatively measures IFN-gamma released from activated NK cells with small amount of blood; and NK365, a proprietary blend of vitamins, minerals, and agaricus mushroom extract for immune system. It also provides recombinant proteins and monoclonal antibodies; and NK PUPPY, a test that measures dog's immunity. The company was formerly known as ATGen Co and changed name to NKMAX CO., Ltd. in 2019. NKMAX CO., Ltd. was founded in 2002 and is headquartered in Seongnam-si, South Korea.
www.nkmax.com--
Full Time Employees
December 31
Fiscal Year Ends
--
Sector
--
Industry
Related News
Performance Overview: 182400.KQ
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 182400.KQ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 182400.KQ
Valuation Measures
Market Cap
--
Enterprise Value
--
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
48.85%
Return on Assets (ttm)
-21.47%
Return on Equity (ttm)
-37.11%
Revenue (ttm)
10.77B
Net Income Avi to Common (ttm)
5.26B
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
914.97M
Total Debt/Equity (mrq)
46.78%
Levered Free Cash Flow (ttm)
-26.49B
Company Insights: 182400.KQ
182400.KQ does not have Company Insights